ZD7-16624-65951
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 920 / CA
- Registered
- 2021-07-09
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-09
Registered in v-safe
-
2021-07-09
Dose 1 — Pfizer-BioNTech
- 2021-07-09
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-17
- 2021-07-24
-
2021-07-30
Dose 2 — Pfizer-BioNTech
- 2021-08-06
- 2021-08-15
- 2021-08-23
- 2021-08-27
- 2021-09-12
-
2022-07-31
Survey response — 12 months, dose 2MedDRA: Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Headache, runny nose, ache, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-07-31
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-09 | Pfizer-BioNTech | No |
| 2 | 2021-07-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-31 | Unsuccessful |
Free text
Release 12 — 12 months, dose 2
Symptoms: Headache, runny nose, ache, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release